Daily Archives: February 28, 2021

In March NIH will start the first variant-specific COVID vaccine study: Will this B.1.351-variant vaccine also induce some immunity to the P.1 variant?

By on .

By Daniel R. Lucey MD, MPH, FIDSA On Friday (Feb. 26) National Institute of Allergy and Intections Diseases Director /NIH Dr. Anthony Fauci, announced plans to start vaccine studies for the first time using the variant B.1.351, now dominant in South Africa and present in the United States. It contains the E484K mutation and also […]